While CRC is on the rise in people under 50, receiving colonoscopies beginning at age 45 can help decrease your risk.

He ditched the bag when he had his colon reattached in ... “This is one of the major signs that we see with patients with colorectal cancer or intestinal cancers in general,” Rivadeneira ...

The FDA has approved Takeda’s Fruzaqla for a group of patients with relapsed or refractory metastatic colorectal cancer, offering another option for patients who have exhausted earlier lines of ...